Clinical Trial: Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD)

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093515) titled 'Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD)' on July 21.

Brief Summary: The BRAIN-CSVD study is a single-center prospective cohort study focusing on cerebral small vessel disease (CSVD).Patients enrolled in this research will undergo assessments for vascular risk factors, cognitive and other neurological functions, neuroimaging, and biomarkers. The study aims to explore imaging and biomarker predictors of CSVD progression, and the pathophysiological mechanisms of CSVD.

Study Start Date: Oct., 2025

Study Type: OBSERVATIONAL

Condition: Cerebral Small Vessel Disease

Int...